Literature DB >> 25950090

Low efficiency IDO2 enzymes are conserved in lower vertebrates, whereas higher efficiency IDO1 enzymes are dispensable.

Hajime J Yuasa1, Keiko Mizuno1, Helen J Ball2.   

Abstract

Indoleamine 2,3-dioxygenase (IDO) is a Trp-degrading enzyme that catalyzes the first step in the kynurenine pathway. Two IDO genes, IDO1 and IDO2, are found in vertebrates and the timing of the gene duplication giving rise to the genes has been controversial. In the present study, we report that several fishes and two turtles also have both IDO1 and IDO2. This represents definitive evidence for the gene duplication occurring before the divergence of vertebrates, with IDO1 having been lost in a number of lower vertebrate lineages. IDO2 enzymes have a relatively low affinity for l-Trp; however, Anolis carolinensis (lizard) IDO2 has an affinity for l-Trp comparable to mammalian IDO1 enzymes. We identified a Ser residue located in the distal heme pocket of IDO1 (distal-Ser) (corresponding to Ser167 of human IDO1) that is conserved in all IDO1 enzymes and the lizard IDO2. This residue is conserved as Thr (distal-Thr) in other IDO2 enzymes. Biochemical analyses, using IDO variants with either Ser or Thr substitutions, suggest that the distal-Ser change was crucial for the improvement in affinity for l-Trp in ancient IDO1. The ancestral IDO1 likely had a 'moderate' enzymatic efficiency for l-Trp, clearly higher than IDO2 but lower than mammalian IDO1. The distal-Ser of lizard IDO2 bestows a high affinity for l-Trp, however, this unique IDO2 has a low enzymatic efficiency because of its very low catalytic velocity. Thus, low efficiency IDO2 enzymes have been conserved throughout vertebrate evolution, whereas higher efficiency IDO1 enzymes are dispensable in many lower vertebrate lineages.
© 2015 FEBS.

Entities:  

Keywords:  Trp metabolism; comparative biochemistry; gene duplication; indoleamine 2,3-dioxygenase; molecular evolution

Mesh:

Substances:

Year:  2015        PMID: 25950090     DOI: 10.1111/febs.13316

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  16 in total

Review 1.  Unbalanced IDO1/IDO2 Endothelial Expression and Skewed Keynurenine Pathway in the Pathogenesis of COVID-19 and Post-COVID-19 Pneumonia.

Authors:  Marco Chilosi; Claudio Doglioni; Claudia Ravaglia; Guido Martignoni; Gian Luca Salvagno; Giovanni Pizzolo; Vincenzo Bronte; Venerino Poletti
Journal:  Biomedicines       Date:  2022-06-06

2.  Effect of water-immersion restraint stress on tryptophan catabolism through the kynurenine pathway in rat tissues.

Authors:  Yoshiji Ohta; Hisako Kubo; Koji Yashiro; Koji Ohashi; Yuji Tsuzuki; Naoya Wada; Yasuko Yamamoto; Kuniaki Saito
Journal:  J Physiol Sci       Date:  2016-06-30       Impact factor: 2.781

3.  IDO2 Modulates T Cell-Dependent Autoimmune Responses through a B Cell-Intrinsic Mechanism.

Authors:  Lauren M F Merlo; James B DuHadaway; Samantha Grabler; George C Prendergast; Alexander J Muller; Laura Mandik-Nayak
Journal:  J Immunol       Date:  2016-04-25       Impact factor: 5.422

4.  Synthesis and evaluation of oxindoles as promising inhibitors of the immunosuppressive enzyme indoleamine 2,3-dioxygenase 1.

Authors:  Saurav Paul; Ashalata Roy; Suman Jyoti Deka; Subhankar Panda; Gopal Narayan Srivastava; Vishal Trivedi; Debasis Manna
Journal:  Medchemcomm       Date:  2017-06-20       Impact factor: 3.597

5.  Sea lampreys elicit strong transcriptomic responses in the lake trout liver during parasitism.

Authors:  Frederick Goetz; Sara E Smith; Giles Goetz; Cheryl A Murphy
Journal:  BMC Genomics       Date:  2016-08-24       Impact factor: 3.969

Review 6.  IDO2: A Pathogenic Mediator of Inflammatory Autoimmunity.

Authors:  Lauren M F Merlo; Laura Mandik-Nayak
Journal:  Clin Med Insights Pathol       Date:  2016-11-21

7.  Upregulation of tryptophanyl-tRNA synthethase adapts human cancer cells to nutritional stress caused by tryptophan degradation.

Authors:  Isabell Adam; Dyah L Dewi; Joram Mooiweer; Ahmed Sadik; Soumya R Mohapatra; Bianca Berdel; Melanie Keil; Jana K Sonner; Kathrin Thedieck; Adam J Rose; Michael Platten; Ines Heiland; Saskia Trump; Christiane A Opitz
Journal:  Oncoimmunology       Date:  2018-09-05       Impact factor: 8.110

8.  Genetic Polymorphisms Affecting IDO1 or IDO2 Activity Differently Associate With Aspergillosis in Humans.

Authors:  Valerio Napolioni; Marilena Pariano; Monica Borghi; Vasilis Oikonomou; Claudia Galosi; Antonella De Luca; Claudia Stincardini; Carmine Vacca; Giorgia Renga; Vincenzina Lucidi; Carla Colombo; Ersilia Fiscarelli; Cornelia Lass-Flörl; Alessandra Carotti; Lucia D'Amico; Fabio Majo; Maria Chiara Russo; Helmut Ellemunter; Angelica Spolzino; Paolo Mosci; Stefano Brancorsini; Franco Aversa; Andrea Velardi; Luigina Romani; Claudio Costantini
Journal:  Front Immunol       Date:  2019-05-07       Impact factor: 7.561

9.  Investigation of the Tissue Distribution and Physiological Roles of Indoleamine 2,3-Dioxygenase-2.

Authors:  Felicita F Jusof; Supun M Bakmiwewa; Silvia Weiser; Lay Khoon Too; Richard Metz; George C Prendergast; Stuart T Fraser; Nicholas H Hunt; Helen J Ball
Journal:  Int J Tryptophan Res       Date:  2017-10-09

10.  Lipopolysaccharide shock reveals the immune function of indoleamine 2,3-dioxygenase 2 through the regulation of IL-6/stat3 signalling.

Authors:  Yasuko Yamamoto; Wakana Yamasuge; Shinjiro Imai; Kazuo Kunisawa; Masato Hoshi; Hidetsugu Fujigaki; Akihiro Mouri; Toshitaka Nabeshima; Kuniaki Saito
Journal:  Sci Rep       Date:  2018-10-29       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.